Surrogate insulin-producing cells.
Diabetes, a large and growing worldwide health concern, affects the functional mass of the pancreatic beta cell, which in turn affects the glucose regulation of the body. Successful transplantation of cadaveric islets and pancreata for patients with uncontrolled type 1 diabetes has provided proof-of-concept for the development of commercial cell therapy approaches to treat diabetes. Three broad issues must be addressed before surrogate insulin-producing cells can become a reality: the development of a surrogate beta-cell source, immunoprotection, and translation. Cell therapy for diabetes is a real possibility, but many questions remain; through the collaborative efforts of multiple stakeholders this may become a reality.
Juvenile Diabetes Research Foundation International 26 Broadway, 14th Floor, New York, NY, 10005 USA.
Adrianne L
AL
Wong
Albert
A
Hwa
Dov
D
Hellman
Julia L
JL
Greenstein